Increasing awareness and knowledge of Alpha-gal Syndrome in the United States

HHS-CDC-NCEZID Posted CDC-RFA-CK-26-0193

Description

The purpose of this NOFO is to improved awareness and knowledge of alpha-gal syndrome (AGS) in the United States. AGS is an emerging condition and is not nationally notifiable. This NOFO seeks to improve AGS surveillance, patient care, and public awareness and understanding. The NOFO strategies are to 1) SHARE - Formation of a network of AGS professionals to disseminate latest knowledge of AGS among stakeholders, including public health agencies, academic researchers, and advocacy groups, in order to improve patient care for AGS and the public health response. 2) EDUCATE - Create AGS communications targeted at the general public, AGS patients, or persons at higher risk for tick encounters (outdoor enthusiasts, dog owners, outdoor workers, etc.). Create communications targeted at healthcare providers including educational resources and training. 3) TRACK - Conduct active or enhances public health surveillance for AGS. This strategy could involve patient populations or geographical locations with limited access to specialized healthcare provider care.

Eligibility

Bona fide agents are eligible to apply. For more information about bona fide agents, please see the CDC webpage on Expediting the Federal Grant Process with an Administrative Partner located at https://www.cdc.gov/publichealthgateway/grantsfunding/expediting.html#Q2
Actions
View on Grants.gov
Funding Details
Award Floor
$25,000.00
Award Ceiling
$1,000,000.00
Total Estimated Funding
$10,000,000.00
Expected Awards
3
Key Dates
Posted
May 19, 2026
Closes
July 9, 2026
Archive Date
August 8, 2026
Agency Information
Agency Name
Centers for Disease Control - NCEZID
Agency Code
HHS-CDC-NCEZID
Funding Instrument
Other